T2 Biosystems, Inc.
TTOO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $10 | $22 | $17 |
| Short-Term Investments | $0 | $0 | $10 | $25 |
| Receivables | $1 | $2 | $5 | $5 |
| Inventory | $5 | $4 | $4 | $4 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $25 | $19 | $44 | $54 |
| Property Plant & Equip (Net) | $9 | $13 | $14 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $2 | $2 | $10 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | $0 | $1 |
| Total NC Assets | $10 | $15 | $16 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $34 | $61 | $79 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $3 | $2 |
| Short-Term Debt | $43 | $3 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $12 | $6 | $7 | $5 |
| Total Curr. Liab. | $56 | $10 | $12 | $10 |
| LT Debt | $7 | $58 | $57 | $56 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $6 | $5 | $4 |
| Total NC Liab. | $7 | $64 | $62 | $61 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $10 | $11 | $12 |
| Total Liabilities | $63 | $74 | $73 | $70 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$584 | -$535 | -$472 | -$423 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $556 | $495 | $459 | $432 |
| Total Equity | -$28 | -$40 | -$13 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $34 | $61 | $79 |
| Net Debt | $34 | $50 | $36 | $41 |